Neothetics to Present at the 15th Annual Needham Healthcare Conference
06 avr. 2016 08h00 HE
|
Neothetics, Inc.
SAN DIEGO, April 06, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today announced that Susan Knudson, Neothetics’ Chief Financial Officer, will present at the 15th Annual Needham...
Neothetics Reports Fourth Quarter 2015 Financial Results
29 mars 2016 08h00 HE
|
Neothetics, Inc.
SAN DIEGO, March 29, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today reported financial results and business progress for the fourth quarter 2015. Fourth Quarter 2015 Highlights ...
Neothetics Provides Update and Plan Forward for LIPO-202 Program
28 mars 2016 08h00 HE
|
Neothetics, Inc.
SAN DIEGO, March 28, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today provided an update and plan forward for its LIPO-202 program. Neothetics plans to initiate a Phase 2 trial with...
Neothetics Announces Leadership Change and Preliminary Update on LIPO-202
18 févr. 2016 16h00 HE
|
Neothetics, Inc.
SAN DIEGO, Feb. 18, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced...
Neothetics Reports LIPO-202 Top-Line Phase 3 Trial Results for the Reduction of Central Abdominal Bulging
14 déc. 2015 16h30 HE
|
Neothetics, Inc.
SAN DIEGO, Dec. 14, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today announced top-line results from its AbCONTOUR1 and AbCONTOUR2 U.S.-based pivotal Phase 3 trials to evaluate the...
Neothetics Announces Issuance by USPTO of Fourth Patent Directed to LIPO-202 Lead Clinical Asset
07 déc. 2015 08h00 HE
|
Neothetics, Inc.
SAN DIEGO, Dec. 7, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...
Neothetics Tightens Guidance for Timing of Top-Line Pivotal Phase 3 Data
01 déc. 2015 07h30 HE
|
Neothetics, Inc.
SAN DIEGO, Dec. 1, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today tightened its...
Neothetics to Present in the 27th Annual Piper Jaffray Healthcare Conference
24 nov. 2015 08h00 HE
|
Neothetics, Inc.
SAN DIEGO, Nov. 24, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, announced today the...
Neothetics Reports Third Quarter 2015 Financial Results
12 nov. 2015 08h00 HE
|
Neothetics, Inc.
SAN DIEGO, Nov. 12, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today reported...
Neothetics to Release Third Quarter 2015 Financial Results
05 nov. 2015 08h00 HE
|
Neothetics, Inc.
SAN DIEGO, Nov. 05, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced...